FAK is also a driver of cholangiocarcinogenesis, and in vivo experiments have shown that ablation of FAK significantly delayed the initiation of Akt/YAP-driven intrahepatic cholangiocarcinoma (iCCA) in mice. This evidence concerns the gene PTK2 and infantile convulsions and choreoathetosis.